The findings warrant confirmation in an independent cohort and since statin use is common in breast cancer patients it would be of interest to study the impact of the ABCB1 genotype in relation to statin use and clinical outcome in a randomized setting, to elucidate the clinical impact of the ABCB1 genotype in breast cancer. This evidence concerns the gene ABCB1 and breast carcinoma.